The U.S. Food and Drug Administration recently issued a warning to the public that Onfi carries a serious risk of skin reactions.
Onfi is an anti-seizure drug that is used in combination with other drugs to treat Lennox-Gastaut Syndrome, a severe form of epilepsy. These severe skin reactions, known as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), can result in long-term injuries and, in some cases, even death. As stated on the FDA’s website, “[a]ll cases ...
continue reading...